ANAB stock news
This page provides real-time market news, earnings updates, and company announcements related to AnaptysBio, Inc. (ANAB).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-08 24:35 EST

Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-03 21:18:44
AnaptysBio, Inc. (ANAB) Q4 Earnings and Revenues Top Estimates
Finviz2026-03-03 23:39:04
Adaptive Biotechnologies (ADPT) Rises 5.8%: Can This Momentum Continue?
101 finance2026-03-16 12:18:45
First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement
Finviz2026-03-27 13:03:56
Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics
Finviz2026-03-27 13:03:55

Anaptys Buyback Expires in Days—Is This Smart Money or a Price-Support Trap?
101 finance2026-03-27 13:21:47
AnaptysBio Inc announced that its subsidiary First Tracks Bio has received approval from the Nasdaq Stock Exchange and will officially initiate "When-Issued Trading" of its shares on April 6, 2026. The trading symbol is set as "Trax".
老虎证券2026-03-27 13:24:16

AnaptysBio Drops 11% Following Spin-Off News and a Turbulent Trading Session
101 finance2026-03-27 16:51:42

AnaptysBio Spin-Off Creates Two Clear Catalysts—First Tracks Bio Gets Funded, Oncology Play Stands Alone
101 finance2026-03-28 23:39:41

AnaptysBio’s Robust Technical Indicators Contradict Its Fragile Fundamentals
101 finance2026-03-30 01:16:02

AnaptysBio Jumps 8.5%: Biotech Turmoil Intensifies Amid Soaring Options Activity and Volatility
101 finance2026-04-06 19:33:51

M&T Bank’s $5 Billion Repurchase Shows Trust in Its Undervalued Business for Long-Term Investors
101 finance2026-04-07 10:03:46
Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics
Finviz2026-03-27 13:03:55

Anaptys Buyback Expires in Days—Is This Smart Money or a Price-Support Trap?
101 finance2026-03-27 13:21:47
AnaptysBio Inc announced that its subsidiary First Tracks Bio has received approval from the Nasdaq Stock Exchange and will officially initiate "When-Issued Trading" of its shares on April 6, 2026. The trading symbol is set as "Trax".
老虎证券2026-03-27 13:24:16

AnaptysBio Drops 11% Following Spin-Off News and a Turbulent Trading Session
101 finance2026-03-27 16:51:42

AnaptysBio Spin-Off Creates Two Clear Catalysts—First Tracks Bio Gets Funded, Oncology Play Stands Alone
101 finance2026-03-28 23:39:41

AnaptysBio’s Robust Technical Indicators Contradict Its Fragile Fundamentals
101 finance2026-03-30 01:16:02

AnaptysBio Jumps 8.5%: Biotech Turmoil Intensifies Amid Soaring Options Activity and Volatility
101 finance2026-04-06 19:33:51

M&T Bank’s $5 Billion Repurchase Shows Trust in Its Undervalued Business for Long-Term Investors
101 finance2026-04-07 10:03:46
ANAB stock chart
ANAB stock detailsANAB stock price change
On the last trading day, ANAB stock closed at 62.43 USD, with a price change of 8.24% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more